Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT02708134

Quality of Pediatric Resuscitation in a Multicenter Collaborative

Quality of Pediatric Resuscitation in a Multicenter Collaborative — Recruiting • Cardiology / Cardiovascular • NCT02708134.

📅 21 Oct 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT02708134
Sponsor
Children's Hospital of Philadelphia
Start
2016-05-02
ClinicaliQ Trial Snapshot
  • Quality of Pediatric Resuscitation in a Multicenter Collaborative — Recruiting • Cardiology / Cardiovascular • NCT02708134.
  • What is being tested: The study examines whether specific chest compression mechanics during pediatric cardiac arrest (rate, depth, flow fraction, and compression release quality) are associated with improved patient survival and neurological outcomes.
  • Patient eligibility overview: This prospective, observational, multi-center cohort study enrolls pediatric patients experiencing in-hospital or out-of-hospital cardiac arrest across participating UK healthcare centres, with data collection on resuscitation quality metrics.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of the study is to determine the association between chest compression mechanics (rate, depth, flow fraction, compression release) and patient outcomes. In addition, the investigators will determine the association of post cardiac arrest care with patient outcomes.

Eligibility Snapshot
  • : * Patient received chest compressions for at least 1 minute * Patient between gestational age ≥37 weeks and 18 years of age

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
‘I was dead for 10 minutes, but lived to tell the tale’
Cardiology / Cardiovascular · BBC Health · 13 Oct 2026
Cardiac arrest survival is possible with rapid intervention: A patient in Spain survived 10 minutes of cardiac arrest, demonstrating the critical importance…
View brief →
Guideline
Artificial intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: early-use assessment
Cardiology / Cardiovascular · 19 May 2026
AI-assisted echocardiography can support faster preliminary analysis and reporting of echo images in heart failure patients, potentially reducing reporting delays and improving…
View guideline →
Clinical Brief
The children dying in India’s remote tribal heartland
Cardiology / Cardiovascular · BBC Health · 30 Sep 2026
Measles and malaria resurgence in vulnerable populations: At least 32 child deaths in Balaghat district highlight ongoing risks in remote tribal areas…
View brief →
Guideline
Finerenone for treating chronic heart failure with preserved or mildly reduced ejection fraction
Cardiology / Cardiovascular · 05 Aug 2026
Finerenone is recommended as an option for chronic heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF) and can be initiated…
View guideline →
Clinical Brief
‘It was heartbreaking to attend a fertility appointment in a maternity unit’
Cardiology / Cardiovascular · BBC Health · 29 Jul 2026
Key Takeaways for Clinical Practice Fertility services co-location with maternity units causes significant emotional harm – patients experiencing recurrent treatment failure and…
View brief →
Guideline
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity
Cardiology / Cardiovascular · 07 May 2026
Semaglutide is recommended for adults with established cardiovascular disease and overweight/obesity to reduce major adverse cardiovascular events – consider prescribing as part…
View guideline →